NIH grant cuts threaten Alzheimer's studies, raising concerns over politicized science

The Trump administration's ongoing review of federal res…

The Trump administration's ongoing review of federal research funding has now reached into the field of neuroscience, with the cancellation of multiple grants at Emory University and the University of Pittsburgh that were focused on Alzheimer's disease and brain health. These terminations are part of a broader effort to strip the National Institutes of Health's $47 billion budget of projects that officials deem politically motivated, with a particular focus on those examining the health effects of systemic racism.

Researchers at both institutions were informed that their projects, which were in various stages of development or execution, would no longer receive federal support. The decision has sparked alarm among scientists, who see it as an unprecedented intrusion into the peer-review process that typically governs grant allocations. Several affected projects had already passed rigorous scientific evaluation and were considered high-priority by NIH panels.

The cancellations appear to be the latest in a series of actions targeting studies that incorporate 'DEI'—diversity, equity, and inclusion—frameworks. The administration has argued that such research wastes taxpayer money and does not align with its priorities of focusing on basic science and direct clinical applications. However, critics contend that the move is politically driven and risks sidelining critical work on health disparities.

Emory and Pittsburgh are not the first institutions

Emory and Pittsburgh are not the first institutions to face such cuts; earlier this year, similar terminations affected projects at other major universities, including those examining environmental health impacts on minority communities. The pattern has led to fears that researchers will self-censor, avoiding topics that might draw political scrutiny, which could stymie innovation and progress in public health.

In response, some members of Congress have demanded an explanation from NIH leadership, questioning the legality of bypassing standard review procedures. Meanwhile, scientific organizations have issued statements defending the value of the affected research, noting that understanding how social factors influence brain health is vital for developing effective treatments and preventive measures.

The long-term consequences of these funding decisions remain uncertain, but the immediate impact is clear: promising research has been halted, and the scientific community is bracing for further disruptions as the administration continues its review of federal grants.